SCHEMBL1695673

SCHEMBL1695673

NC(=O)CNC(=O)COc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.63
HPGD P15428 3/20 0.63
POLB P06746 2/20 0.58
PKM P14618 1/20 0.58
ALOX15 P16050 1/20 0.58
MEN1 O00255 4/20 0.57
ALPL P05186 1/20 0.56
ALPI P09923 1/20 0.56
ALPG P10696 1/20 0.56
NPC1 O15118 2/20 0.55
USP2 O75604 1/20 0.55
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
HTT P42858 2/20 0.54
GAA P10253 2/20 0.54
GLA P06280 1/20 0.54
ERCC1 P07992 1/20 0.52
ERCC4 Q92889 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227121 0.86 POLB (0.55) KMT2AHPGDPOLBPKMMEN1
SCHEMBL7821754 0.86 ALOX15 (0.68) KMT2AHPGDPOLBPKMALOX15
SCHEMBL11775788 0.84 KMT2A (0.69) KMT2AHPGDPOLBPKMALOX15
SCHEMBL27995932 0.83 LMNA (0.57) KMT2AHPGDPKMALOX15MEN1
SCHEMBL11253171 0.83 NPC1 (0.60) KMT2AHPGDMEN1ALPLALPI
SCHEMBL10948513 0.83 KMT2A (0.63) KMT2AHPGDPOLBPKMALOX15
SCHEMBL10948507 0.83 KMT2A (0.63) KMT2AHPGDPOLBPKMALOX15
SCHEMBL11393650 0.83 KMT2A (0.63) KMT2AHPGDPOLBPKMALOX15
SCHEMBL11162047 0.81 KMT2A (0.61) KMT2AHPGDPOLBPKMALOX15
SCHEMBL7890148 0.79 NPC1 (0.63) KMT2AHPGDPOLBALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011139636-A1 SMALL MOLECULE INHIBITORS OF FUNCTIONS OF THE HIV-1 MATRIX PROTEIN PHILADELPHIA HEALTH & EDUCATION CORPORATION (US) 2011-11-10 WO disclosed
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US disclosed
EP-1105387-B1 PRODRUGS OF PROTON PUMP INHIBITORS WINSTON PHARMATEUTICALS LLC (US) 2003-01-29 EP disclosed
EP-1105387-A1 PRODRUGS OF PROTON PUMP INHIBITORS Partnership of Michael E. Garst, George Sachs and Jai Moo Shin (US) 2001-06-13 EP disclosed
WO-2000009498-A1 PRODRUGS OF PROTON PUMP INHIBITORS PARTNERSHIP OF MICHAEL E. GARST, GEORGE SACHS AND JAI MOO SHIN (US) 2000-02-24 WO disclosed
EP-0019411-B1 1-PHENYL-2-AMINOETHANOL DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS THEREOF IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-12-22 EP disclosed